TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS

Technology
E-035-2018
Patent ID
E-035-2018-0-US-03
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
 
Publication Number
US-2021-0000926-A1
Application Number
16/968,792
IC
NIAID
Date Filed
Date Issued
 
Patent PDF